Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irving W Wainer

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 24, 2009
A novel class of allosteric modulators of AMPA/Kainate receptorsGiuseppe Cannazza, Krzysztof Jozwiak, Carlo Parenti, et al.
Chirality|June 30, 2012
The stereoselective sulfate conjugation of 4'-methoxyfenoterol stereoisomers by sulfotransferase enzymesLalitha V Iyer, Anuradha Ramamoorthy, Ewelina Rutkowska, et al.
Scientific Reports|May 6, 2021
Author Correction: Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot studyAndrew McGarry, John Gaughan, Cory Hackmyer, et al.
Pharmacology Research & Perspectives|December 16, 2014
Antitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouseMichel Bernier, Rajib K Paul, Katina S S Dossou, et al.
Biochimica Et Biophysica Acta|March 23, 2010
Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational statesHugo R Arias, Avraham Rosenberg, Dominik Feuerbach, et al.
Biochemical Pharmacology|December 21, 2013
(R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motilityRajib K Paul, Artur Wnorowski, Isabel Gonzalez-Mariscal, et al.
European Journal of Pharmacology|November 28, 2012
Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptorsRuin Moaddel, Galia Abdrakhmanova, Joanna Kozak, et al.
Bioorganic & Medicinal Chemistry|December 29, 2009
Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonistsKrzysztof Jozwiak, Anthony Yiu-Ho Woo, Mary J Tanga, et al.
Current Pain and Headache Reports|July 16, 2021
Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and ToxicityEric S Schwenk, Basant Pradhan, Rohit Nalamasu, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depressionXiaochen Zhao, Swarajya Lakshmi Vattem Venkata, Ruin Moaddel, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Bioorganic & Medicinal Chemistry Letters|January 24, 2009
A novel class of allosteric modulators of AMPA/Kainate receptorsGiuseppe Cannazza, Krzysztof Jozwiak, Carlo Parenti, et al.
Chirality|June 30, 2012
The stereoselective sulfate conjugation of 4'-methoxyfenoterol stereoisomers by sulfotransferase enzymesLalitha V Iyer, Anuradha Ramamoorthy, Ewelina Rutkowska, et al.
Scientific Reports|May 6, 2021
Author Correction: Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot studyAndrew McGarry, John Gaughan, Cory Hackmyer, et al.
Pharmacology Research & Perspectives|December 16, 2014
Antitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouseMichel Bernier, Rajib K Paul, Katina S S Dossou, et al.
Biochimica Et Biophysica Acta|March 23, 2010
Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational statesHugo R Arias, Avraham Rosenberg, Dominik Feuerbach, et al.
Biochemical Pharmacology|December 21, 2013
(R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motilityRajib K Paul, Artur Wnorowski, Isabel Gonzalez-Mariscal, et al.
European Journal of Pharmacology|November 28, 2012
Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptorsRuin Moaddel, Galia Abdrakhmanova, Joanna Kozak, et al.
Bioorganic & Medicinal Chemistry|December 29, 2009
Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonistsKrzysztof Jozwiak, Anthony Yiu-Ho Woo, Mary J Tanga, et al.
Current Pain and Headache Reports|July 16, 2021
Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and ToxicityEric S Schwenk, Basant Pradhan, Rohit Nalamasu, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depressionXiaochen Zhao, Swarajya Lakshmi Vattem Venkata, Ruin Moaddel, et al.
Pageof 14